This provider's $4.3M in total Medicare payments ranks in the 98th percentile of Nuclear Medicine providers nationally.
Medicare payments to this provider grew 11019% from 2014 to 2023.
88% of their billing comes from a single procedure code (A9607 — Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie).
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 2909% in 2023
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $255.33 | $61.25 | 4.17x | $194.08 | $35.3K | 576 | 12 |
| 2015 | $252.79 | $56.99 | 4.44x | $195.80 | $29.9K | 524 | 13 |
| 2016 | $250.50 | $57.66 | 4.34x | $192.84 | $29.2K | 507 | 13 |
| 2017 | $247.98 | $62.92 | 3.94x | $185.06 | $36.2K | 576 | 13 |
| 2018 | $233.55 | $58.33 | 4.00x | $175.22 | $42.3K | 725 | 18 |
| 2019 | $255.39 | $63.30 | 4.03x | $192.09 | $35.5K | 561 | 13 |
| 2020 | $270.13 | $66.41 | 4.07x | $203.72 | $25.7K | 387 | 12 |
| 2021 | $619.24 | $156.63 | 3.95x | $462.61 | $61.4K | 392 | 12 |
| 2022 | $1.1K | $289.12 | 3.90x | $837.31 | $130.4K | 451 | 11 |
| 2023 | $417.49 | $187.30 | 2.23x | $230.19 | $3.9M | 20.9K | 8 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| A9607 | Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie | 20.4K | $3.8M | $187.53 | 2.18x |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | 1.6K | $301.5K | $193.51 | 3.78x |
| 74177 | Ct scan of abdomen and pelvis with contrast | 548 | $39.4K | $71.99 | 5.36x |
| 78816 | Nuclear medicine study whole body with ct scan | 195 | $30.2K | $154.99 | 3.77x |
| 70491 | Ct scan of soft tissue of neck with contrast | 574 | $28.8K | $50.19 | 4.18x |
| 71260 | Ct scan of chest with contrast | 559 | $25.1K | $44.92 | 5.79x |
| 78812 | Nuclear medicine study from skull base to mid-thigh | 276 | $19.0K | $68.85 | 3.47x |
| 79101 | Radioactive drug therapy through a vein | 104 | $12.5K | $120.49 | 2.20x |
| 78072 | Imaging of parathyroid with ct and nuclear medicine study | 183 | $11.0K | $60.05 | 1.60x |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 127 | $10.5K | $82.82 | 7.97x |
| 78306 | Nuclear medicine study of bone and/or joint whole body | 327 | $10.2K | $31.06 | 4.90x |
| 78582 | Nuclear medicine study of lung ventilation and circulation | 223 | $9.0K | $40.32 | 2.99x |
| 78803 | Nuclear medicine study, 1 area with spect | 122 | $4.9K | $40.00 | 3.90x |
| 78598 | Nuclear medicine study with measurement of blood circulation in the lungs and ventilation | 113 | $3.4K | $30.30 | 3.30x |
| 74176 | CT scan of abdomen and pelvis | 45 | $3.1K | $68.20 | 5.28x |
| 78452 | Nuclear medicine study of vessels of heart using drugs or exercise multiple studies | 49 | $3.0K | $61.42 | 3.76x |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | 16 | $2.6K | $162.38 | 2.28x |
| 70490 | CT scan of neck | 46 | $2.2K | $46.77 | 4.15x |
| 71250 | CT scan chest | 50 | $1.9K | $38.81 | 4.51x |
| 78315 | Bone and/or joint imaging, 3 phase study | 46 | $1.7K | $37.78 | 6.02x |
This provider submits charges 2.41 times higher than what Medicare actually pays.
A markup ratio of 2.41x means for every $100 Medicare pays, this provider initially charges $241. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data